Company intelligence / Profile preview

Drake Holding

Las Vegas, Nevada, United States

Ownership: Private
Development stage: Other

Overview

Canopus BioPharma (formerly Drake Holding Corp.) was a biopharmaceutical company dedicated to developing and commercializing therapeutic products for oncology, infectious diseases, and inflammatory conditions. The company's pipeline included candidates for the treatment of influenza and chemotherapy-induced stomatitis, as well as diagnostic tools for personalized medicine. Following a series of corporate restructurings and name changes, the entity pivoted its business model and currently operates in the beverage industry as Blue Heaven Coffee.

Therapeutic areas: OncologyGastroenterologyDermatologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Food & Nutrition

Beyond the preview

Go deeper on Drake Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drake Holding.

Explore the full profile